Ahead of elections, one notes that pan-Blue politicians are suddenly changing their tunes on cross-strait relations. This is particularly true with regard to how they articulate Taiwan’s relationship with the US. Such moves take place, however, at a time in which the pan-Blue camp’s cross-strait policy has been overshadowed by former president Ma Ying-jeou’s historic trip to China, as the first former Taiwanese leader to visit China in 70 years, in a similar timeframe to stopovers in the US by current president Tsai Ing-wen in which she met with US Speaker of the House Kevin McCarthy...
FoxConn founder Terry Gou announced his intentions to run for president earlier this week. Gou emphasized that he believed that “Taiwan needs a great CEO” to serve as its leader...
Speculation is on the rise regarding who the KMT intends to field for its next presidential candidate. All indications are that there will be significant in-fighting in the KMT on this matter...
FoxConn founder Terry Gou has recently begun publicly criticizing the Central Epidemic Command Center that coordinates Taiwan’s COVID-19 strategy over its apparent failure to purchase BioNTech vaccines. Instead, Taiwan is primarily depending on the next-generation Moderna bivalent vaccines for its next round of vaccinating the population against COVID-19...
The offices of TPP legislator Ann Kao, who is the mayor-elect of Hsinchu, were searched by prosecutors yesterday. Kao and other witnesses were also questioned by prosecutors...
A new resolution passed by the KMT’s Central Standing Committee earlier this month provides an amnesty period, allowing for members that left or were kicked out of the KMT to rejoin before February 17th. This move is part of an initiative by recently elected chair Eric Chu to open the door for old members that have since left the party...
A controversy broke out last week regarding the packaging of BioNTech vaccines sent to Taiwan. Much of this controversy has proven hard to sort out from conflicting news reports and what are likely attempts by the Chinese government to disseminate disinformation, so as to affect the political credibility of the Tsai administration...
It has proven an odd twist that the manufacturing giant FoxConn and Chang Ya-chung, the head of the Sun Yat-Sen School and the pro-unification Chinese Integration Association, have announced plans to purchase vaccines in the past few days. Although FoxConn CEO Terry Gou claims that he intend to purchase German BioNTech vaccines for Taiwan, not Chinese vaccines, BioNTech's past record makes a strong case for skepticism. Chang's actions are further suspicious, as his actions suggest murky links to Shanghai Fosun, in seeking to purchase both BioNTech and Sinopharm vaccines. Sinopharm is 49% owned by Shanghai Fosun, ostensibly BioNtech's Greater China market distributor, as a joint venture with the Chinese government...
